The Danish Safety Technology Authority controls the compliance with the rules. It is stated in Section 32 of Danish Act No. 1169 of 4 November 2024 on tobacco products etc.
Manufacturers and importers of tobacco surrogates marketed in Denmark are required to report information about the product, including ingredients, for each tobacco surrogate divided by trade name. This is stated in Section 3a in the Danish Act No. 1161 of 4 November 2024 on tobacco products etc.
When changing the composition and content of already reported tobacco surrogates, a new report must be made, cf. No. 1. It is stated in Section 3 No. 2 of Executive Order No. 243 of 22 February 2021 on the reporting of tobacco surrogates etc.
Whoever markets a tobacco surrogate in Denmark must ensure that each individual pack and any outer packaging does not contain elements or features that i.a. encourages use or gives a false impression of the product, gives the impression that a product is less harmful than other products, gives a positive impression or gives the impression that a product is energizing, healing or has ecological properties, etc. This is stated in Section 3 of Executive Order No. 462 of 18. March 2021 on labeling and health warnings on tobacco surrogates.
Marketing is making the product available to consumers with or without payment. In case of cross-border distance sales, the goods or products are considered to have been marketed in the country where the consumer is located. This appears in Section 2 of Executive Order No. 243 of 22 February 2021 on the reporting of tobacco surrogates etc.
The Danish Safety Technology Authority can prohibit the marketing of tobacco surrogates if the reporting has not been made according to Section 3a No. 1. It is stated in Section 36 of Danish Act no. 1489 of 18 June 2021 on tobacco products etc.
